inflamed pharma
PrivateLast Round
Grant
Mar 23, 2020
Company Overview
inflamed pharma is a biotechnology company that provides a patented technology platform, JenCluTec®, to increase the water solubility and membrane permeability of small molecules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inflamed pharma Comparables
Compare inflamed pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zerion Pharma | 86% | |
| Harpago | 82% | |
| AustinPx | 79% |
inflamed pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 23, 2020 |
inflamed pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Regional Development Fund | Grant |
| Xlife Sciences AG | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2020
Received grant funding from the European Regional Development Fund.
inflamed pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about inflamed pharma's valuation, stock price, and market status.
Is inflamed pharma a public or private company?
inflamed pharma is a private company.
What is the current stock price of inflamed pharma?
inflamed pharma is a private company with no public stock price. No recent secondary market data is available.
How much is inflamed pharma worth (valuation)?
Valuation information for inflamed pharma is not publicly available.
Can I buy inflamed pharma stock?
inflamed pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was inflamed pharma's last funding round?
Funding round information for inflamed pharma is not publicly available.
Who are the main investors in inflamed pharma?
Investor information for inflamed pharma is not publicly disclosed.
Will inflamed pharma IPO soon?
No public IPO plans have been announced for inflamed pharma.
How can I track inflamed pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor inflamed pharma's secondary market activity and sign up for updates.